Since the high probability of development of Type 2 diabetes in females with a history of GDM may be explained on the basis of pregnancy-induced acceleration of pancreatic β-cell secretory exhaustion, treatment that would produce a β-cell-sparing effect on endogenous insulin secretion could prove beneficial. Here, INS is linked to gestational diabetes.